50090-1302 : Atovaquone and Proguanil Hydrochloride Oral Tablet, Film Coated


NDC: 50090-1302
Labeler: A-s Medication Solutions
Product Type: Human Prescription Drug
Drug Name:  Atovaquone and Proguanil Hydrochloride
Dosage Form: Oral Tablet, Film Coated
Application #: ANDA091211
Rev. Date: 


Appearance:


Markings: 404;G
Shapes:  Round
Colors:  Pink
Size (mm): 11
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

404 G: (68462-404) Atovaquone and Proguanil Hydrochloride Oral Tablet, Film Coated by A-s Medication Solutions
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 50090-1302-0: 7 TABLET, FILM COATED IN 1 BOTTLE (50090‑1302‑0)
  • 50090-1302-1: 12 TABLET, FILM COATED IN 1 BOTTLE (50090‑1302‑1)
  • 50090-1302-2: 14 TABLET, FILM COATED IN 1 BOTTLE (50090‑1302‑2)
  • 50090-1302-3: 16 TABLET, FILM COATED IN 1 BOTTLE (50090‑1302‑3)
  • 50090-1302-4: 24 TABLET, FILM COATED IN 1 BOTTLE (50090‑1302‑4)
  • 50090-1302-5: 5 TABLET, FILM COATED IN 1 BOTTLE (50090‑1302‑5)
  • 50090-1302-6: 10 TABLET, FILM COATED IN 1 BOTTLE (50090‑1302‑6)
  • 50090-1302-7: 100 TABLET, FILM COATED IN 1 BOTTLE (50090‑1302‑7)
  • 50090-1302-8: 20 TABLET, FILM COATED IN 1 BOTTLE (50090‑1302‑8)
  • 50090-1302-9: 30 TABLET, FILM COATED IN 1 BOTTLE (50090‑1302‑9)

Active Ingredients:

  • Atovaquone
  • Proguanil Hydrochloride

Dosage Strength:

  • 250 mg
  • 100 mg

Inactive Ingredients:

  • Microcrystalline Cellulose
  • Low-substituted Hydroxypropyl Cellulose, Unspecified
  • Poloxamer 188
  • Povidone K30
  • Silicon Dioxide
  • Magnesium Stearate
  • Polyethylene Glycol 400
  • Polyethylene Glycol 8000
  • Titanium Dioxide
  • Ferric Oxide Red
  • Hypromellose 2910 (15 Mpa.s)
  • Sodium Starch Glycolate Type a Potato

Pharmaceutical Classes:

  • Antimalarial [EPC]
  • Antiprotozoal [EPC]
  • Dihydrofolate Reductase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0378-4160 Atovaquone and Proguanil Hydrochloride Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
  • 0378-4162 Atovaquone and Proguanil Hydrochloride Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
  • 10544-909 Atovaquone and Proguanil Hydrochloride Oral Tablet, Film Coated by Blenheim Pharmacal, Inc.
  • 33261-900 Atovaquone 250 mg / Proguanil Hydrochloride 100 mg Oral Tablet by Aidarex Pharmaceuticals LLC
  • 42254-150 Atovaquone 250 mg / Proguanil Hydrochloride 100 mg Oral Tablet by Rebel Distributors Corp
  • 43063-393 Atovaquone 250 mg / Proguanil Hydrochloride 100 mg Oral Tablet by Pd-rx Pharmaceuticals, Inc.
  • 53034-404 Atovaquone 250 mg / Proguanil Hydrochloride 100 mg Oral Tablet by Clinical Solutions
  • 54868-6393 Atovaquone 250 mg / Proguanil Hydrochloride 100 mg Oral Tablet by Physicians Total Care, Inc.
  • 58118-0404 Atovaquone 250 mg / Proguanil Hydrochloride 100 mg Oral Tablet by Clinical Solutions Wholesale
  • 60760-498 Atovaquone and Proguanil Hydrochloride Oral Tablet, Film Coated by St. Mary's Medical Park Pharmacy
  • 63187-879 Atovaquone and Proguanil Hydrochloride Oral Tablet, Film Coated by Proficient Rx Lp
  • 68001-245 Atovaquone and Proguanil Hydrochloride Oral Tablet, Film Coated by Bluepoint Laboratories
  • 68071-3473 Atovaquone and Proguanil Hydrochloride Oral Tablet, Film Coated by Nucare Pharmaceuticals, Inc.
  • 68071-3488 Atovaquone and Proguanil Hydrochloride Oral Tablet, Film Coated by Nucare Pharmaceuticals, Inc.
  • 68258-1104 Atovaquone 250 mg / Proguanil Hydrochloride 100 mg Oral Tablet by Dispensing Solutions, Inc.
  • 68462-404 Atovaquone 250 mg / Proguanil Hydrochloride 100 mg Oral Tablet by Glenmark Generics Inc., USA
  • 68462-563 Atovaquone 62.5 mg / Proguanil Hydrochloride 25 mg Oral Tablet by Glenmark Generics Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50090-1302 QR Code

< Prev: 50090-1301Next: 50090-1304 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.